Why Applying Machine Learning to Biology is Hard – But Worth It

Why Applying Machine Learning to Biology is Hard – But Worth It

In today's world, the intersection of technology and biology holds immense potential for advancements in various fields. However, applying machine learning to biology is not without its challenges. The complexities involved in this process require a unique set of skills and expertise. To build a balanced techbio company, there are three types of people you need to hire.

The first group you need to bring on board are the biologists. These individuals have a deep understanding of the biological systems and processes that underpin life. They possess great imagination and intuition about mechanisms and complexity. Biologists work with things that are often invisible, and their ability to visualize molecular events is invaluable. Their expertise in study design and asking the right questions is crucial when adapting biological studies to the realm of machine learning.

On the other end of the spectrum, you need to have a team of tech experts. These individuals are well-versed in machine learning techniques and methodologies. They understand how to work with large datasets and are skilled in statistical learning and deep learning methods. Their knowledge of existing tools and algorithms is essential for leveraging the potential of biomolecular data. However, it is important to note that adapting these methods to the unique characteristics of biological data may require some modifications.

The third type of person you need to hire is the bridger - someone who can effectively communicate and collaborate between the tech and bio teams. These individuals have fluency in both areas and can bridge the gap between the two disciplines. They understand the nuances of both fields and can facilitate effective collaboration and knowledge exchange. Finding such individuals may be challenging, but their role is crucial for the success of any techbio company.

When combining machine learning and biology, it is essential to be mindful of the limitations and traps that may arise. One such challenge is the "big-p little-n problem." In biology, we often have billions of data points for each individual, but a relatively small number of samples. This poses a challenge for traditional machine learning approaches, as the number of features exceeds the number of samples. To overcome this, it is important to carefully featurize the data and optimize for machine learning at every step of the process, from study design to data analysis.

Additionally, it is crucial to control for confounders and ensure consistency across different sites. When dealing with large amounts of data, there is a risk of overfitting, where the model becomes too specific to the training data and fails to generalize to new data. To mitigate this, rigorous validation and cross-validation techniques should be employed.

One approach that has gained traction in the field of computational biology is multiomics analysis. This approach integrates data sets generated by various 'omics' technologies, such as genomics, transcriptomics, proteomics, and metabolomics. By combining these different layers of biological information, researchers can gain a more comprehensive understanding of complex biological phenomena.

In the pursuit of bridging the gap between technology and biology, it is important to strike a balance and invest in both fields equally. Many companies tend to lean heavily towards one side or the other, which can hinder the full potential of interdisciplinary collaboration. By fostering a collaborative environment where both tech and bio domains are valued, true advancements can be made.

The ultimate goal of applying machine learning to biology is to unlock new insights and possibilities. One exciting prospect is the ability to detect diseases before symptoms manifest. By analyzing vast amounts of data, machine learning algorithms can identify patterns and biomarkers that indicate the presence of a disease. Early detection can significantly improve treatment outcomes and potentially save lives.

In conclusion, the marriage of machine learning and biology is a challenging yet rewarding endeavor. By hiring a balanced team comprising biologists, tech experts, and bridgers, companies can harness the power of interdisciplinary collaboration. Adapting existing methods and tools to the unique characteristics of biomolecular data is crucial, as is being mindful of the limitations and pitfalls that may arise. By integrating multiple 'omics' data sets and optimizing for machine learning, researchers can gain deeper insights into the complexities of life. Three actionable pieces of advice for companies venturing into this field are:

1. Foster a collaborative environment where both tech and bio expertise are valued and integrated.
2. Invest in rigorous study design and data analysis techniques to optimize for machine learning.
3. Seek out individuals who can bridge the gap between tech and bio domains.

By following these guidelines, companies can navigate the challenges and fully realize the potential of applying machine learning to biology. The possibilities for advancements in healthcare, agriculture, and other fields are immense, and the rewards are well worth the effort.